Tech Times Weekly Wrap brings you the top news from last week to get you up to date for this upcoming one, centering on the latest developments in the world of tech, with the controversial firing of Sam Altman from OpenAI headlining the roundup. It joins the FAA's announcement of granting SpaceX the launch license for its Starship, focusing on its second test flight.
A new cancer treatment in the form of a liquid gel also joins the roundup, promising its effects on solid cancer tumors present in a patient.
Sam Altman Faces the Ax from OpenAI Shocking the World
Last week, OpenAI released a blog post that shocked the world, and even more so, their employees who only found out about its co-founder and former CEO, Sam Altman, axed from his position last Thursday. In a surprise move by the renowned AI company, Altman was fired as the CEO of the company because he failed to be "candid in his communications with the board."
According to the blog post, Altman was subjected to a deliberative review process by the company, praising his many efforts to grow the company into where it is now.
However, the board claimed that it lost confidence in Altman's ability and performance as the CEO, replacing him with an interim CEO the company appointed Mira Murati to take over its operations.
SpaceX's Starship Granted its Second Launch License
The US Federal Aviation Authority granted SpaceX its second launch license last Tuesday, November 14, giving the Starship the green light for its tests to determine its capabilities. This follows the earlier announcement by SpaceX and Elon Musk that the Starship is ready on the Boca Chica launch pad for its proposed orbital flight, completing all the corrective actions after its explosion in April.
Over the weekend, the Starship launched early Saturday morning and was able to propel farther compared to its first-ever test earlier this year, seeing its separation from the Super Heavy Booster rocket and going on its way. According to CNN's report, while the Starship went farther than it ever has and reached the outer edge of the atmosphere, the Super Heavy was lost in the process before also losing the signal of the main spacecraft.
New Cancer Treatment in the Form of a Gel
The Mass General Brigham, in collaboration with the Koch Institute for Integrative Cancer Research, is looking to develop a gel delivery system that aims to treat cancer. The said gel was said to be capable of fighting metastatic cancers with injection as its method of delivery, claiming that in its preclinical models, could help induce tumor regression.
Its release claimed that it would be directly injected into tumors, offering a new way that would ensure a successful delivery of the drug to overcome the challenges faced before.
The team published their study in the Advanced Healthcare Materials journal and said that its testing showed improved survival rates, first done on mice.
Related Article : Image of Missing ISS Crew Lock Bag Spotted Drifting in Earth Orbit
